ReadCoor readcoor.com


Public list: Digital Health (6540) Genomics (615)

ReadCoor delivers a panomic spatial sequencing platform to a global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It seeks to accomplish this with a technology called FISSEQ, which simultaneously enables integration of high throughput sequencing, morphometric analysis, cellular location and three-dimensional spatial imaging.

ReadCoor delivers a panomic spatial sequencing platform to a global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It seeks to accomplish this with a technology called FISSEQ, which simultaneously enab...Show all

Company (Alive / Active)

Phone: 617-453-2660

Fax:

840 Memorial Dr
5th Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ReadCoor $52.4M Oct 18, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ReadCoor Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Bill & Melinda Gates FoundationNon-Profit FoundationSeattle, Washington, United StatesGrant
Decheng CapitalVenture CapitalShanghai, Shanghai, ChinaSeries B, Series A
Hansjörg WyssAngel Investor (Individual)Series A
Chan Zuckerberg InitiativeNon-Profit FoundationUnited StatesGrant - II
Hansjorg WyssAngel Investor (Individual)SwitzerlandSeries B
See all 9 investors

Competitors

Company Status Description Investors

Patents

Title Application Date Patent Date Status
(Patent / Application)